Why have ten or so nontoxic, retrovirus integrase inhibitors not been made available for AIDS treatment? A ten-year experiment must liberate them [editorial] NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Why have ten or so nontoxic, retrovirus integrase inhibitors not been made available for AIDS treatment? A ten-year experiment must liberate them [editorial]

Biomed Pharmacother. 1999 Dec;53(10):484-6. Unique Identifier : AIDSLINE MED/20128727
Mathe G


Abstract: We detected in 1989, with the inhibitor test of proviral insertion into c-erb B erythroblastosis, two retrovirus integrase inhibitors: hydroxy-methyl-ellipticine and acriflavine. They have been used for ten years in AIDS patients with high efficacy and no toxicity. Since vitamin B12 and cobalt, which it contains, have been detected as HIV1-integrase inhibitors by an in-vitro test, we have also used vitamin B12 (combined with folic acid), whose clinical action has been remarkable. Ten or so other compounds have been detected by such in-vitro tests, among which there are many compounds (such as flavones) which are used in many conditions and are not toxic.


Keywords: EDITORIAL REVIEW REVIEW, TUTORIAL JOURNAL ARTICLE Acquired Immunodeficiency Syndrome/*DRUG THERAPY Acriflavine/PHARMACOLOGY/*THERAPEUTIC USE Cobalt/PHARMACOLOGY Ellipticines/PHARMACOLOGY/*THERAPEUTIC USE Human HIV Integrase/METABOLISM HIV Integrase Inhibitors/PHARMACOLOGY/*THERAPEUTIC USE HIV-1/DRUG EFFECTS/ENZYMOLOGY Vitamin B 12/PHARMACOLOGY/THERAPEUTIC USEKWDeditorialreviewreview,tutorialjournalarticleacquiredimmunodeficiencysyndrome/KWDdrugtherapyacriflavine/pharmacology/KWDtherapeuticusecobalt/pharmacologyellipticines/pharmacology/KWDtherapeuticusehumanhivintegrase/metabolismhivintegraseinhibitors/pharmacology/KWDtherapeuticusehiv-1/drugeffects/enzymologyvitaminb12/pharmacology/therapeuticuse
000530
A0052213

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .